Frequently Asked Questions
The global shock wave therapy market was valued at USD 1186.5 Million in 2022.
The shock wave therapy market is expected to grow at a CAGR of 7.2% between 2023 and 2030, reaching USD 2069.31 Million in 2030.
Electrohydraulic shock wave therapy (ESWT) is the leading segment by technology, holding over 40% share in value in 2022.
The urology segment governs the global demand for shock wave therapy, holding a massive share of over 30% in 2022.
The clinics and rehabilitation centers segment will post the highest CAGR over the projection period.
With more than one-third of the market in 2022, North America is driving the expansion of the shock wave therapy industry.
The top players include Dornier MedTech, Shockwave Medical Inc, BTL Industries, EDAP TMS, Boston Scientific Corporation, Bio-Med Inc, Inceler Medikal Co. Ltd, Karl Storz SE & Co. KG, EMS Dolorclast, and Others.
The major market drivers of the shock wave therapy industry include the rising prevalence of musculoskeletal and orthopedic conditions, especially among the aging population, and the increasing demand for non-invasive treatment options.
The major market restraints of the shock wave therapy industry comprise regulatory variations across regions, which can result in delays and complexities for manufacturers and safety and efficacy concerns, particularly related to improper use and long-term outcomes.
The major market opportunities of the shock wave therapy industry encompass expanding applications in various medical specialties beyond musculoskeletal disorders and the potential for global market expansion in emerging economies, where healthcare investments and access to innovative treatments are on the rise.